Vivo Infusion completed the acquisition of Infusion Associates from Boyne Capital.

Vivo Infusion, a provider of accessible, affordable, and safe community-based infusion and injection care, completed the acquisition of Infusion Associates, a provider of ambulatory infusion services, from Boyne Capital, a private equity firm. Financial terms were not disclosed. "Boyne has been a valuable partner to Infusion Associates, taking a hands-on and collaborative approach to help us establish the team, systems and capabilities that have been foundational to our success. Together we have positioned the Company for continued growth as part of the Vivo Infusion platform, and I am grateful to Boyne for their support. I would also like to thank the amazing Infusion Associates team that has helped us continuously reach greater heights while maintaining a best-in-class patient experience every step of the way," Chuck Jett, Infusion Associates CEO.